Last 12 months
Inside the activity.
0 purchase rows · 10 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 02, 2026 Filed Sep 4, 2026 21:00 UTC |
Berkshire James G.See Remarks
|
Exercise / conversionStock Appreciation Right · Derivative | 5,381 | $131.82 Strike: $131.82 | $709,323.42 |
DisclosureSEC source: 0001628280-26-060755 · wk-form4_1788555634.xml · derivative · entry 4 Berkshire James G. · CIK 0002103773 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,381 shares Expires 2029-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 21:00 UTC |
Berkshire James G.See Remarks
|
Disposition to issuerCommon Stock | 2,713 | $261.54 | $709,558.02 |
DisclosureSEC source: 0001628280-26-060755 · wk-form4_1788555634.xml · nonDerivative · entry 3 Berkshire James G. · CIK 0002103773 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,177 Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 21:00 UTC |
Berkshire James G.See Remarks
|
SaleCommon Stock | 2,668 | $261.33 | $697,228.44 |
DisclosureSEC source: 0001628280-26-060755 · wk-form4_1788555634.xml · nonDerivative · entry 2 Berkshire James G. · CIK 0002103773 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,890 Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 21:00 UTC |
Berkshire James G.See Remarks
|
Exercise / conversionCommon Stock | 5,381 | $131.82 | $709,323.42 |
DisclosureSEC source: 0001628280-26-060755 · wk-form4_1788555634.xml · nonDerivative · entry 1 Berkshire James G. · CIK 0002103773 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2026 Filed Aug 4, 2026 21:00 UTC |
STAUB W RICHARDSee Remarks
|
SaleCommon Stock | 5,500 | $232.68 | $1,279,740.00 |
DisclosureSEC source: 0001628280-26-052703 · wk-form4_1785877251.xml · nonDerivative · entry 1 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,312 Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 21:00 UTC |
Patel BhavikSee Remarks
|
SaleCommon Stock | 1,855 | $235.27 | $436,425.85 |
DisclosureSEC source: 0001628280-26-052701 · wk-form4_1785877210.xml · nonDerivative · entry 1 Patel Bhavik · CIK 0002023629 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,348 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.22 to $235.29, inclusive. Read SEC document |
| July 29, 2026 Filed Jul 31, 2026 21:03 UTC |
Cherofsky KeriannSee Remarks
|
SaleCommon Stock | 558 | $245.21 | $136,827.18 |
DisclosureSEC source: 0001628280-26-051450 · wk-form4_1785531795.xml · nonDerivative · entry 1 Cherofsky Keriann · CIK 0001940591 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,989 Read SEC document |
| July 29, 2026 Filed Jul 31, 2026 21:04 UTC |
Sherbet EricSee Remarks
|
SaleCommon Stock | 5,000 | $249.16 | $1,245,800.00 |
DisclosureSEC source: 0001628280-26-051451 · wk-form4_1785531837.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,999 Read SEC document |
| July 29, 2026 Filed Jul 31, 2026 21:02 UTC |
BOUSBIB ARIDirector · See Remarks
|
Exercise / conversionStock Appreciation Right · Derivative | 156,206 | $78.21 Strike: $78.21 | $12,216,871.26 |
DisclosureSEC source: 0001628280-26-051449 · wk-form4_1785531724.xml · derivative · entry 9 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 156,206 shares Expires 2027-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 29, 2026 Filed Jul 31, 2026 21:02 UTC |
BOUSBIB ARIDirector · See Remarks
|
Disposition to issuerCommon Stock | 2,069 | $247.00 | $511,043.00 |
DisclosureSEC source: 0001628280-26-051449 · wk-form4_1785531724.xml · nonDerivative · entry 7 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 835,941 F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2027. Read SEC document |
| July 29, 2026 Filed Jul 31, 2026 21:02 UTC |
BOUSBIB ARIDirector · See Remarks
|
Disposition to issuerCommon Stock | 47,858 | $244.60 | $11,706,066.80 |
DisclosureSEC source: 0001628280-26-051449 · wk-form4_1785531724.xml · nonDerivative · entry 6 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 838,010 F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2027. Read SEC document |
| July 29, 2026 Filed Jul 31, 2026 21:02 UTC |
BOUSBIB ARIDirector · See Remarks
|
SaleCommon Stock | 53,191 | $244.78 | $13,020,092.98 |
DisclosureSEC source: 0001628280-26-051449 · wk-form4_1785531724.xml · nonDerivative · entry 5 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 885,868 F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2027. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.60 to $245.60, inclusive. Read SEC document |
| July 29, 2026 Filed Jul 31, 2026 21:02 UTC |
BOUSBIB ARIDirector · See Remarks
|
SaleCommon Stock | 44,039 | $246.08 | $10,837,117.12 |
DisclosureSEC source: 0001628280-26-051449 · wk-form4_1785531724.xml · nonDerivative · entry 4 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 939,059 F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2027. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.70 to $246.58, inclusive. Read SEC document |
| July 29, 2026 Filed Jul 31, 2026 21:02 UTC |
BOUSBIB ARIDirector · See Remarks
|
SaleCommon Stock | 4,584 | $246.85 | $1,131,560.40 |
DisclosureSEC source: 0001628280-26-051449 · wk-form4_1785531724.xml · nonDerivative · entry 3 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 983,098 F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2027. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.70 to $247.05, inclusive. Read SEC document |
| July 29, 2026 Filed Jul 31, 2026 21:02 UTC |
BOUSBIB ARIDirector · See Remarks
|
SaleCommon Stock | 4,465 | $247.10 | $1,103,301.50 |
DisclosureSEC source: 0001628280-26-051449 · wk-form4_1785531724.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 987,682 F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2027. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $247.00 to $247.18, inclusive. Read SEC document |
| July 29, 2026 Filed Jul 31, 2026 21:02 UTC |
BOUSBIB ARIDirector · See Remarks
|
Exercise / conversionCommon Stock | 156,206 | $78.21 | $12,216,871.26 |
DisclosureSEC source: 0001628280-26-051449 · wk-form4_1785531724.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 992,147 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2027. Read SEC document |
| July 14, 2026 Filed Jul 16, 2026 21:02 UTC |
DANHAKL JOHN GDirector
|
GrantDeferred Shares · Derivative | 160 | $207.83 | $33,252.80 |
DisclosureSEC source: 0001628280-26-048501 · wk-form4_1784235766.xml · derivative · entry 1 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,289 Underlying: Common Stock · 160 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| July 14, 2026 Filed Jul 16, 2026 21:04 UTC |
Wims Morris LeslieDirector
|
GrantDeferred Shares · Derivative | 148 | $207.83 | $30,758.84 |
DisclosureSEC source: 0001628280-26-048504 · wk-form4_1784235857.xml · derivative · entry 1 Wims Morris Leslie · CIK 0001908079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,784 Underlying: Common Stock · 148 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| July 14, 2026 Filed Jul 16, 2026 21:03 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 183 | $207.83 | $38,032.89 |
DisclosureSEC source: 0001628280-26-048503 · wk-form4_1784235824.xml · derivative · entry 1 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,297 Underlying: Common Stock · 183 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| July 14, 2026 Filed Jul 16, 2026 21:03 UTC |
Fasano JimDirector
|
GrantDeferred Shares · Derivative | 195 | $207.83 | $40,526.85 |
DisclosureSEC source: 0001628280-26-048502 · wk-form4_1784235796.xml · derivative · entry 1 Fasano Jim · CIK 0001633043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,268 Underlying: Common Stock · 195 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:05 UTC |
DANHAKL JOHN GDirector
|
GrantDeferred Shares · Derivative | 185 | $178.64 | $33,048.40 |
DisclosureSEC source: 0001628280-26-033650 · wk-form4_1778533546.xml · derivative · entry 1 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,129 Underlying: Common Stock · 185 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:07 UTC |
Wims Morris LeslieDirector
|
GrantDeferred Shares · Derivative | 171 | $178.64 | $30,547.44 |
DisclosureSEC source: 0001628280-26-033655 · wk-form4_1778533671.xml · derivative · entry 1 Wims Morris Leslie · CIK 0001908079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,636 Underlying: Common Stock · 171 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:07 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 214 | $178.64 | $38,228.96 |
DisclosureSEC source: 0001628280-26-033654 · wk-form4_1778533645.xml · derivative · entry 1 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,114 Underlying: Common Stock · 214 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:06 UTC |
Fasano JimDirector
|
GrantDeferred Shares · Derivative | 228 | $178.64 | $40,729.92 |
DisclosureSEC source: 0001628280-26-033653 · wk-form4_1778533610.xml · derivative · entry 1 Fasano Jim · CIK 0001633043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,073 Underlying: Common Stock · 228 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 21:01 UTC |
DANHAKL JOHN GDirector
|
GrantCommon Stock | 1,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-027604 · wk-form4_1777323689.xml · nonDerivative · entry 1 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 30,612 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. F2 · ownership.nature: Shares held in the Danhakl Revocable Family Trust. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 21:00 UTC |
Burt CarolDirector
|
GrantCommon Stock | 1,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-027596 · wk-form4_1777323609.xml · nonDerivative · entry 1 Burt Carol · CIK 0001493926 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 7,533 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. F2 · ownership.nature: Shares held in Carol Burt Hilliard Revocable Trust. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 21:04 UTC |
Stamps Sheila ADirector
|
GrantDeferred Shares · Derivative | 1,571 | $160.68 | $252,428.28 |
DisclosureSEC source: 0001628280-26-027612 · wk-form4_1777323882.xml · derivative · entry 1 Stamps Sheila A · CIK 0001600782 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,210 Underlying: Common Stock · 1,571 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 21:04 UTC |
Wims Morris LeslieDirector
|
GrantDeferred Shares · Derivative | 1,571 | $160.68 | $252,428.28 |
DisclosureSEC source: 0001628280-26-027611 · wk-form4_1777323847.xml · derivative · entry 1 Wims Morris Leslie · CIK 0001908079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,465 Underlying: Common Stock · 1,571 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 21:03 UTC |
Kaelin William G JrDirector
|
GrantDeferred Shares · Derivative | 1,571 | $160.68 | $252,428.28 |
DisclosureSEC source: 0001628280-26-027610 · wk-form4_1777323825.xml · derivative · entry 1 Kaelin William G Jr · CIK 0001551715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,571 Underlying: Common Stock · 1,571 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 21:03 UTC |
LEONARD JOHN MDirector
|
GrantCommon Stock | 1,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-027609 · wk-form4_1777323780.xml · nonDerivative · entry 1 LEONARD JOHN M · CIK 0001563584 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,946 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 21:02 UTC |
GOGGINS COLLEEN ADirector
|
GrantCommon Stock | 1,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-027607 · wk-form4_1777323751.xml · nonDerivative · entry 1 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,453 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 21:01 UTC |
Fasano JimDirector
|
GrantDeferred Shares · Derivative | 1,571 | $160.68 | $252,428.28 |
DisclosureSEC source: 0001628280-26-027605 · wk-form4_1777323714.xml · derivative · entry 1 Fasano Jim · CIK 0001633043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,845 Underlying: Common Stock · 1,571 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 22:01 UTC |
Haas BerndSee Remarks
|
Tax withholdingCommon Stock | 20 | $166.94 | $3,338.80 |
DisclosureSEC source: 0001628280-26-008661 · wk-form4_1771365705.xml · nonDerivative · entry 1 Haas Bernd · CIK 0002104344 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,394 Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 22:01 UTC |
Fedock Michael J.See Remarks
|
Tax withholdingCommon Stock | 123 | $166.94 | $20,533.62 |
DisclosureSEC source: 0001628280-26-008659 · wk-form4_1771365667.xml · nonDerivative · entry 1 Fedock Michael J. · CIK 0002103784 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,472 Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 22:08 UTC |
Cherofsky KeriannSee Remarks
|
GrantStock Appreciation Right · Derivative | 2,795 | $0.00 Strike: $192.67 | $0.00 |
DisclosureSEC source: 0001628280-26-007352 · wk-form4_1770847730.xml · derivative · entry 1 Cherofsky Keriann · CIK 0001940591 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,795 Underlying: Common Stock · 2,795 shares Expires 2036-02-09 F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2027. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 22:05 UTC |
DANHAKL JOHN GDirector
|
GrantDeferred Shares · Derivative | 172 | $192.67 | $33,139.24 |
DisclosureSEC source: 0001628280-26-007344 · wk-form4_1770847554.xml · derivative · entry 1 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,944 Underlying: Common Stock · 172 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 22:10 UTC |
Patel BhavikSee Remarks
|
GrantStock Appreciation Right · Derivative | 11,180 | $0.00 Strike: $192.67 | $0.00 |
DisclosureSEC source: 0001628280-26-007356 · wk-form4_1770847849.xml · derivative · entry 1 Patel Bhavik · CIK 0002023629 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,180 Underlying: Common Stock · 11,180 shares Expires 2036-02-09 F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2027. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 22:11 UTC |
STAUB W RICHARDSee Remarks
|
GrantStock Appreciation Right · Derivative | 26,088 | $0.00 Strike: $192.67 | $0.00 |
DisclosureSEC source: 0001628280-26-007358 · wk-form4_1770847901.xml · derivative · entry 1 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,088 Underlying: Common Stock · 26,088 shares Expires 2036-02-09 F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2027. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 22:11 UTC |
Sherbet EricSee Remarks
|
GrantStock Appreciation Right · Derivative | 12,112 | $0.00 Strike: $192.67 | $0.00 |
DisclosureSEC source: 0001628280-26-007357 · wk-form4_1770847877.xml · derivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,112 Underlying: Common Stock · 12,112 shares Expires 2036-02-09 F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2027. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 22:10 UTC |
Haas BerndSee Remarks
|
GrantStock Appreciation Right · Derivative | 11,180 | $0.00 Strike: $192.67 | $0.00 |
DisclosureSEC source: 0001628280-26-007355 · wk-form4_1770847826.xml · derivative · entry 1 Haas Bernd · CIK 0002104344 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,180 Underlying: Common Stock · 11,180 shares Expires 2036-02-09 F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2027. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 22:10 UTC |
Grenfell AlistairSee Remarks
|
GrantStock Appreciation Right · Derivative | 26,088 | $0.00 Strike: $192.67 | $0.00 |
DisclosureSEC source: 0001628280-26-007354 · wk-form4_1770847801.xml · derivative · entry 1 Grenfell Alistair · CIK 0002104640 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,088 Underlying: Common Stock · 26,088 shares Expires 2036-02-09 F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2027. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 22:09 UTC |
Fedock Michael J.See Remarks
|
GrantStock Appreciation Right · Derivative | 18,634 | $0.00 Strike: $192.67 | $0.00 |
DisclosureSEC source: 0001628280-26-007353 · wk-form4_1770847762.xml · derivative · entry 1 Fedock Michael J. · CIK 0002103784 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,634 Underlying: Common Stock · 18,634 shares Expires 2036-02-09 F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2027. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 22:08 UTC |
Berkshire James G.See Remarks
|
GrantStock Appreciation Right · Derivative | 11,180 | $0.00 Strike: $192.67 | $0.00 |
DisclosureSEC source: 0001628280-26-007350 · wk-form4_1770847705.xml · derivative · entry 1 Berkshire James G. · CIK 0002103773 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,180 Underlying: Common Stock · 11,180 shares Expires 2036-02-09 F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2027. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 22:08 UTC |
BOUSBIB ARIDirector · See Remarks
|
GrantStock Appreciation Right · Derivative | 78,264 | $0.00 Strike: $192.67 | $0.00 |
DisclosureSEC source: 0001628280-26-007349 · wk-form4_1770847681.xml · derivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,264 Underlying: Common Stock · 78,264 shares Expires 2036-02-09 F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2027. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 22:07 UTC |
Wims Morris LeslieDirector
|
GrantDeferred Shares · Derivative | 159 | $192.67 | $30,634.53 |
DisclosureSEC source: 0001628280-26-007348 · wk-form4_1770847634.xml · derivative · entry 1 Wims Morris Leslie · CIK 0001908079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,894 Underlying: Common Stock · 159 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 22:06 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 198 | $192.67 | $38,148.66 |
DisclosureSEC source: 0001628280-26-007347 · wk-form4_1770847610.xml · derivative · entry 1 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,900 Underlying: Common Stock · 198 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 22:06 UTC |
Fasano JimDirector
|
GrantDeferred Shares · Derivative | 211 | $192.67 | $40,653.37 |
DisclosureSEC source: 0001628280-26-007346 · wk-form4_1770847585.xml · derivative · entry 1 Fasano Jim · CIK 0001633043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,274 Underlying: Common Stock · 211 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 22:46 UTC |
Cherofsky KeriannSee Remarks
|
Tax withholdingCommon Stock | 415 | $187.49 | $77,808.35 |
DisclosureSEC source: 0001628280-26-006955 · wk-form4_1770763581.xml · nonDerivative · entry 2 Cherofsky Keriann · CIK 0001940591 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,547 Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 22:46 UTC |
Cherofsky KeriannSee Remarks
|
GrantCommon Stock | 1,087 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-006955 · wk-form4_1770763581.xml · nonDerivative · entry 1 Cherofsky Keriann · CIK 0001940591 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,962 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2023. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 8, 2026. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 22:50 UTC |
Patel BhavikSee Remarks
|
Tax withholdingCommon Stock | 1,920 | $187.49 | $359,980.80 |
DisclosureSEC source: 0001628280-26-006964 · wk-form4_1770763843.xml · nonDerivative · entry 2 Patel Bhavik · CIK 0002023629 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,203 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.